{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:01:10Z","timestamp":1793944870532,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000006","name":"Office of Naval Research","doi-asserted-by":"publisher","award":["N00014-23-1-2057"],"award-info":[{"award-number":["N00014-23-1-2057"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jcyt.2024.11.001","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:18:39Z","timestamp":1731673119000},"page":"300-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Harnessing global HLA data for enhanced patient matching in iPSC haplobanks"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-2064","authenticated-orcid":false,"given":"Martin","family":"Maiers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McClain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7078-5283","authenticated-orcid":false,"given":"Christina","family":"Leonhard-Melief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc L.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4007-6248","authenticated-orcid":false,"given":"David","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2024.11.001_bib0001","doi-asserted-by":"crossref","unstructured":"Fairchild, PJ, C Horton, P Lahiri, K Shanmugarajah, and TJ Davies. 2016. \u201cBeneath the sword of Damocles: regenerative medicine and the shadow of immunogenicity.\u201d Regenerat Med 11: 817\u201329. https:\/\/doi.org\/10.2217\/rme-2016-0134.","DOI":"10.2217\/rme-2016-0134"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0002","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/s42003-021-02237-4","article-title":"Immunological considerations and challenges for regenerative cellular therapies","volume":"4","author":"Petrus-Reurer","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-014-9574-4","article-title":"Banking on iPSC\u2014is it doable and is it worthwhile","volume":"11","author":"Solomon","year":"2015","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0004","doi-asserted-by":"crossref","unstructured":"Crow, D 2019. \u201cCould iPSCs enable \u2018off-the-shelf\u2019 cell therapy?\u201d Cell 177 1667\u201369. https:\/\/doi.org\/10.1016\/j.cell.2019.05.043.","DOI":"10.1016\/j.cell.2019.05.043"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0005","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/cells8050403","article-title":"Current challenges of iPSC-based disease modeling and therapeutic implications","volume":"8","author":"Doss","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0006","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.stemcr.2023.03.005","article-title":"History and current status of clinical studies using human pluripotent stem cells","volume":"18","author":"Kobold","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102035","article-title":"Haplobanking induced pluripotent stem cells for clinical use","volume":"49","author":"Sullivan","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0008","doi-asserted-by":"crossref","first-page":"10441","DOI":"10.1073\/pnas.1902566116","article-title":"Generation of hypoimmunogenic human pluripotent stem cells","volume":"116","author":"Han","year":"2019","journal-title":"Proceed Natl Acad Sci USA"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0009","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s13287-021-02301-0","article-title":"Evaluation of the Spanish population coverage of a prospective HLA haplobank of induced pluripotent stem cells","volume":"12","author":"\u00c1lvarez-Palomo","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/stem.2865","article-title":"Repurposing the Cord Blood Bank for haplobanking of HLA-homozygous iPSCs and their usefulness to multiple populations","volume":"36","author":"Lee","year":"2018","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0011","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(05)67813-0","article-title":"Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching","volume":"366","author":"Taylor","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.835321","article-title":"Creation of GMP-compliant iPSCs from Banked Umbilical Cord Blood","volume":"10","author":"Tian","year":"2022","journal-title":"Front Cell Develop Biol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0013","first-page":"51","article-title":"A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population","volume":"4","author":"Yoshida","year":"2023","journal-title":"Med (New York, N.Y.)"},{"issue":"7","key":"10.1016\/j.jcyt.2024.11.001_bib0014","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.3390\/jcm9072217","article-title":"HLA-matched allogeneic iPS cells-derived RPE transplantation for macular degeneration","volume":"9","author":"Sugita","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","article-title":"Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0016","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-00926-5","article-title":"MHC matching improves engraftment of iPSC-derived neurons in non-human primates","volume":"8","author":"Morizane","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0018","doi-asserted-by":"crossref","unstructured":"Gourraud, P-A, G Leena, M Girard, and M Peschanski. 2012. \u201cThe role of human leukocyte antigen matching in the development of multiethnic \u2018haplobank\u2019 of induced pluripotent stem cell lines.\u201d Stem Cells (Dayton, Ohio) 30: 180\u201386. https:\/\/doi.org\/10.1002\/stem.772.","DOI":"10.1002\/stem.772"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0019","doi-asserted-by":"crossref","first-page":"413","DOI":"10.5966\/sctm.2015-0052","article-title":"Proceedings: human leukocyte antigen haplo-homozygous induced pluripotent stem cell haplobank modeled after the California population: evaluating matching in a multiethnic and admixed population","volume":"4","author":"Pappas","year":"2015","journal-title":"Stem Cells Translat Med"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nbt0708-739","article-title":"HLA-haplotype banking and iPS cells","volume":"26","author":"Nakatsuji","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0021","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC Bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0022","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13287-022-02961-6","article-title":"Public Cord Blood Banks as a source of starting material for clinical grade HLA-homozygous induced pluripotent stem cells","volume":"13","author":"Alvarez-Palomo","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2020.102036","article-title":"The Global Alliance for iPSC Therapies (GAiT)","volume":"49","author":"Sullivan","year":"2020","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0024","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/rme.15.1","article-title":"Development of a global network of induced pluripotent stem cell haplobanks","volume":"10","author":"Wilmut","year":"2015","journal-title":"Regenerat Med"},{"issue":"9","key":"10.1016\/j.jcyt.2024.11.001_bib43","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/stem.3003","article-title":"\u201cA Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017\u201d","volume":"37","author":"Jung-Hyun","year":"2019","journal-title":"Stem Cells (Dayton, Ohio)"},{"issue":"7","key":"10.1016\/j.jcyt.2024.11.001_bib45","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2217\/rme-2018-0095","article-title":"\u201cQuality Control Guidelines for Clinical-Grade Human Induced Pluripotent Stem Cell Lines\u201d","volume":"13","author":"Stephen","year":"2018","journal-title":"Regenerative Medicine"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0026","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.humimm.2021.07.001","article-title":"HLA haplotype frequency estimation for heterogeneous populations using a graph-based imputation algorithm","volume":"82","author":"Israeli","year":"2021","journal-title":"Human Immunol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2023.110721","article-title":"Combined imputation of HLA genotype and self-identified race leads to better donor-recipient matching","volume":"84","author":"Israeli","year":"2023","journal-title":"Human Immunol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0028","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s13287-022-03182-7","article-title":"Blood Donor Biobank and HLA imputation as a resource for HLA homozygous cells for therapeutic and research use","volume":"13","author":"Clancy","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1069749","article-title":"Trans-population graph-based coverage optimization of allogeneic cellular therapy","volume":"14","author":"Israeli","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0030","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720926151","article-title":"Umbilical cord blood units cryopreserved in the Public Cord Blood Bank: a breakthrough in iPSC haplobanking?","volume":"29","author":"Roh","year":"2020","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0031","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.stemcr.2023.09.001","article-title":"Creating an HLA-homozygous iPS Cell Bank for the Brazilian population: challenges and opportunities","volume":"18","author":"Oliveira","year":"2023","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.001_bib44","doi-asserted-by":"crossref","first-page":"518135","DOI":"10.1155\/2014\/518135","article-title":"Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy","volume":"2014","author":"de Rham","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0032","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1097\/TXD.0000000000001312","article-title":"HLA homozygosity and likelihood of sensitization in kidney transplant candidates","volume":"8","author":"Rushakoff","year":"2022","journal-title":"Transplant Direct"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0033","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.stemcr.2017.07.020","article-title":"NK cell alloreactivity against KIR-ligand-mismatched HLA-haploidentical tissue derived from HLA haplotype-homozygous iPSCs","volume":"9","author":"Ichise","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0034","doi-asserted-by":"crossref","first-page":"e14606","DOI":"10.1111\/petr.14606","article-title":"HLA (Emphasis on DQ) compatibility for longer allograft survival in pediatric transplantation: modern evidence and challenges","volume":"28","author":"Meneghini","year":"2024","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0035","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3324\/haematol.2021.280055","article-title":"Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation","volume":"108","author":"Ruggeri","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0036","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbmt.2010.09.012","article-title":"HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation","volume":"17","author":"Woolfrey","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.2517-6161.1977.tb01600.x","article-title":"Maximum likelihood from incomplete data via the EM algorithm","volume":"39","author":"Dempster","year":"1977","journal-title":"J Royal Stat Soc"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0038","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0039","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/01621459.1996.10476908","article-title":"Multiple imputation after 18 + years","volume":"91","author":"Rubin","year":"2011","journal-title":"J Am Stat Assoc"},{"issue":"10","key":"10.1016\/j.jcyt.2024.11.001_bib42","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1093\/stcltm\/szac060","article-title":"Identification and re-consent of existing cord blood donors for creation of induced pluripotent stem cell lines for potential clinical applications","volume":"11","author":"Abberton","year":"2022","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0040","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/vox.13687","article-title":"Criteria for storage of cord blood units at Japan's largest Cord Blood Bank","volume":"119","author":"Watanabe-Okochi","year":"2024","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.jcyt.2024.11.001_bib0041","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41409-024-02246-x","article-title":"Remuneration of donors for cell and gene therapies: an update on the principles and perspective of the World Marrow Donor Association","volume":"59","author":"Hamad","year":"2024","journal-title":"Bone Marrow Transplant"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324924009265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T03:59:10Z","timestamp":1750132750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324924009265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1465324924009265"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.11.001","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.10.15.618361","asserted-by":"object"}]},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing global HLA data for enhanced patient matching in iPSC haplobanks","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2024.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}]}}